# Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

> **NCT01240538** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 26 (actual)

## Conditions studied

- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** wild-type reovirus
- **DRUG:** cyclophosphamide
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT01240538
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-04
- **Final completion:** —
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240538, "Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01240538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*